NCT01328158View on ClinicalTrials.gov

Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection

CompletedOBSERVATIONAL
Enrollment

236

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Human Immunodeficiency Virus Infection
Trial Locations (23)

Unknown

Site Reference ID/Investigator# 57629, Fukuoka

Site Reference ID/Investigator# 57630, Hiroshima

Site Reference ID/Investigator# 57631, Hokkaido

Site Reference ID/Investigator# 57628, Kitakyushu-shi

Site Reference ID/Investigator# 57638, Kurashiki-shi

Site Reference ID/Investigator# 57634, Kyoto

Site Reference ID/Investigator# 57625, Nagoya

Site Reference ID/Investigator# 57626, Nagoya

Site Reference ID/Investigator# 57637, Niigata

Site Reference ID/Investigator# 57632, Nishinomiya-shi

Site Reference ID/Investigator# 57639, Osaka

Site Reference ID/Investigator# 57640, Osaka

Site Reference ID/Investigator# 57636, Sendai

Site Reference ID/Investigator# 48722, Tokyo

Site Reference ID/Investigator# 57641, Tokyo

Site Reference ID/Investigator# 57643, Tokyo

Site Reference ID/Investigator# 57644, Tokyo

Site Reference ID/Investigator# 57645, Tokyo

Site Reference ID/Investigator# 57646, Tokyo

Site Reference ID/Investigator# 57647, Tokyo

Site Reference ID/Investigator# 57648, Tokyo

Site Reference ID/Investigator# 57650, Tokyo

Site Reference ID/Investigator# 57633, Yokohama

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01328158 - Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection | Biotech Hunter | Biotech Hunter